JD Esq - Kineta General Secretary
Executive
JD Esq is General Secretary of Kineta Inc
| Age | 50 |
| Phone | 206 378 0400 |
| Web | https://kinetabio.com |
Kineta Management Efficiency
The company has Return on Asset (ROA) of (1.1408) % which means that for every 100 dollars spent on asset, it generated a loss of $1.1408. This is way below average. Likewise, it shows a return on total equity (ROE) of (3.6901) %, which implies that it produced no returns to current stockholders. Kineta's management efficiency ratios could be used to measure how well Kineta manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Robert Hendriks | Molecular Partners AG | N/A | |
| Lorianne MD | DiaMedica Therapeutics | 64 | |
| Pamela Trail | Molecular Partners AG | 69 | |
| David MD | Mineralys Therapeutics, Common | 70 | |
| Samuel MD | Tempest Therapeutics | 58 | |
| Erin OBoyle | Rezolute | N/A | |
| Jessica Ibbitson | Mineralys Therapeutics, Common | N/A | |
| Michael Covarrubias | Rezolute | N/A | |
| Julie CCRP | DiaMedica Therapeutics | 50 | |
| Ana Rodriguez | Dyadic International | N/A | |
| Hayley Parker | PepGen | N/A | |
| Cindy Berejikian | Mineralys Therapeutics, Common | N/A | |
| Dana Alexander | Allovir | 48 | |
| MD MBA | Silo Pharma | 59 | |
| Michelle MD | PepGen | 49 | |
| Daniel Steiner | Molecular Partners AG | N/A | |
| MS MD | DiaMedica Therapeutics | 51 | |
| Renate Gloggner | Molecular Partners AG | 55 | |
| Stefan Abele | Pharvaris BV | 55 | |
| Daniel George | Anebulo Pharmaceuticals | 55 | |
| Mary JD | PepGen | 57 | |
Management Performance
| Return On Equity | -3.69 | |||
| Return On Asset | -1.14 |
Kineta Inc Leadership Team
Elected by the shareholders, the Kineta's board of directors comprises two types of representatives: Kineta inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Kineta. The board's role is to monitor Kineta's management team and ensure that shareholders' interests are well served. Kineta's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Kineta's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Craig Philips, President Secretary | ||
| Gary Gentges, Executive Development | ||
| Jacques Bouchy, Executive Development | ||
| JD Esq, General Secretary | ||
| Thierry Guillaudeux, Chief Officer | ||
| Shawn Iadonato, Chair CEO | ||
| Keith Baker, Chief Officer |
Kineta Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Kineta a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.69 | |||
| Return On Asset | -1.14 | |||
| Current Valuation | 5.7 M | |||
| Shares Outstanding | 12.26 M | |||
| Shares Owned By Insiders | 34.89 % | |||
| Shares Owned By Institutions | 6.00 % | |||
| Number Of Shares Shorted | 28.54 K | |||
| Price To Book | 9.65 X | |||
| Price To Sales | 1.44 X | |||
| Revenue | 5.44 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Consideration for investing in Kineta Stock
If you are still planning to invest in Kineta Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Kineta's history and understand the potential risks before investing.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |